期刊文献+

胱抑素C的生物学特征及其临床应用 被引量:8

下载PDF
导出
摘要 临床上常用的反映肾小球滤过率(GFR)的血尿素氮(BUN )、血清肌酐(sCr)、内生肌酐清除率(Ccr)等由于有一定的局限性,不能正确反映GFR 。胱抑素 C(CysC)是近年研究发现的一种特异性高、准确性好,较 Ccr 更为敏感的评价 GFR 的新指标[1]。 CysC 作为一种测定 GFR 的内源性物质,由于其不受许多生理因素的影响,同 GFR 其他标志物相比具有许多独特的优点,临床研究也证实了 CysC 在一系列生理病理过程发挥着作用,并有重要的临床意义。
作者 尤冬梅
出处 《山西医药杂志》 CAS 2015年第8期895-897,共3页 Shanxi Medical Journal
  • 相关文献

参考文献14

二级参考文献165

共引文献183

同被引文献82

  • 1Villa P, Jim6nez M, Soriano M C, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients[J]. Critical Care, 2005, 9(2): 139-143.
  • 2Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J]. American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation, 2000, 36(1): 29-34.
  • 3Mariani M, Mariani G, De Servi S. Clinical Significance of Cystatin C in Acute Coronary Syndromes: Something More Than a Marker of Renal Function?[J]. Inflammation and Cell Signaling, 2014, 1(6): e229. doi: 10,14800/ics,229.
  • 4Bengtsson E, To F, Grubb A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice[J]. Atherosclerosis, 2005, 180(1): 45-53.
  • 5Angelidis C, Deftereos S, Giannopoulos G, et al. Cystatin C: an emerging biomarker in cardiovascular disease[J]. Current topics in medicinal chemistry, 2013, 13(2): 164-179.
  • 6Ribeiro HB, Larose E, de la Paz RM, et al. Myocardial injury following transcatheter aortic valve implantation: insights from delayed- enhancement cardiovascular magnetic resonance[J]. Eurointervention: journal of EuroPCR in collaboration with the Working Group on Intervendonal Cardiology of tlre European Society of Cardiology, 2015, 11(2): 205-213.
  • 7Munk PS, Breland UM, Aukrust P, et al. High intensity interval training reduces systemic inflammation in post-PCI patients[J]. European Journal of Cardiovascular Prevention & Rehabilitation, 2011, 18(6): 850-857.
  • 8Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults[J]. Annals of Internal Medicine, 2005, 142(7): 497-505.
  • 9Waheed S, Matsushita K, Sang Y, et al. Combined association of albuminuria and cystatin C based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study[J]. American Journal of Kidney Diseases, 2012, 60(2): 207-216.
  • 10Ix JH, Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study[J]. Circulation, 2007, 115(2): 173-179.

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部